An alarming number of individuals suffering from osteoarthritis (OA) has fueled innovation of next-gen viscosupplements. Companies in the viscosupplementation market are increasing efforts to deliver formulations that result in long-lasting pain relief. For instance, Articulate Biosciences - a pre-seed medical device startup, has gained expertise in the development of next-gen, cartilage-protecting viscosupplement that provides significantly longer pain relief to OA patients. The key to success in the market for viscosupplementation is longer pain relief and restoration of mobility in OA patients. Such innovations are bolstering market growth, where the market is estimated to reach a value of ~US$ 4.8 Bn by the end of 2027.
Novel biomimetic polymer viscosupplements are increasingly replacing in-development osteoarthritis joint injections. Hence, companies in the viscosupplementation market are increasing R&D in biocompatible polymers, since these polymers are extensively used in FDA-approved stents, contact lenses, and surgical meshes. The market is witnessing a change with the introduction of biocompatible polymers that prevent degradation associated with hyaluronic acid.
Innovations in intra-articular single-injection viscosupplements are generating revenue opportunities for healthcare companies. This is justified since the revenue of single-injection products is predicted to experience an uptick in the viscosupplementation market. Companies are developing viscosupplements that stay for a prolonged period in the knee joint cavity. For instance, Seikagaku Corporation- a Japan-based pharmaceutical company, announced the launch of HyLink®, a CE marked intra-articular single-injection viscosupplement used for the treatment of knee osteoarthritis through MDM S.p.A., a pharmaceutical company involved in active marketing of high-value therapeutic solutions in Italy. As such, the revenue of knee osteoarthritis application segment is projected for exponential growth in the viscosupplementation market.
Companies in the market for viscosupplementation are increasing their research efforts in cross-linked hyaluronate hydrogel, which stays longer in the knee joint cavity and offers pain relief for prolonged weeks. Manufacturers in the market for viscosupplementation are setting their collaboration wheels in motion by entering into exclusive distributorship agreements to strategically target OA patients.
The viscosupplementation market is projected to expand at a CAGR of ~7% during the forecast period. Since companies have established a strong business hold in North America, they are now turning toward Asia Pacific to unearth revenue streams, since this market in Asia Pacific is anticipated for aggressive growth. India being one of the rapidly growing economies of Asia Pacific, is grabbing the attention of healthcare companies and researchers to develop products through deep understanding of patients and clinician needs. However, it has been found that there is a dearth of robust evidence supporting the effectiveness of viscosupplementation or intra-articular hyaluronic acid (IAHA) treatment, which is likely to hamper market growth.
Nonoperative treatment approaches such as viscosupplementation and IAHA delay the need for total knee replacement surgeries in patients who are not ideal candidates for invasive treatment methods. However, the lack of clinical evidence on the safety and effectiveness of IAHA has created barriers for market growth in India. Thus, companies in the viscosupplementation market should increase efforts to collect consensus-based expert statements that can guide practitioners on IAHA use.
Apart from knee OA, companies in the viscosupplementation market are seeking value growth by increasing treatment options for hip and hand OA. Manufacturers are increasing their production capabilities to develop innovative synovial fluids that thicken up when pressure is applied and act as shock absorbing materials. The growing availability of synthetic products are triggering the growth of the viscosupplementation market. This is evident since non-animal sourced products are anticipated for exponential growth in the market landscape.
Companies in the market for viscosupplementation are increasing awareness about combination treatments such as gel injections with knee bracing to improve patient outcomes. It has been found that gel injections may be more effective when combined with knee bracing. This combination treatment are benefitting patients with moderate-grade knee arthritis. Likewise, companies are increasing R&D activities to develop combination therapies using stem cell for patients with severe knee arthritis.
Analysts’ Viewpoint
Apart from retail pharmacies, companies in the viscosupplementation market are directing their supply chains toward online pharmacies, since this distribution channel is projected for aggressive growth during the forecast period. Companies are focusing on innovations in 3-injection regimens using sodium hyarulonate acid.
IAHA has helped to delay the need for total knee replacement surgeries in patients who are not ideal for surgical treatments. However, the lack of evidence on the safety and effectiveness of IAHA has slowed down market growth. Hence, companies should aim toward collecting consensus-based expert statements through government-held advisory board meetings that can guide practitioners on the IAHA use.
Major Players
Viscosupplementation Market - Segmentation
TMR’s study on the global viscosupplementation market includes information divided into five segments: product type, source, application, distribution channel, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global viscosupplementation market have been discussed in detail.
|
Product Type |
Single Injection Three Injections Five Injections |
|
Application |
Knee Osteoarthritis Hip Osteoarthritis Hand Osteoarthritis |
|
Source |
Animal Non-animal |
|
Distribution Channel |
Retail Pharmacies Hospital Pharmacies Online Pharmacies |
|
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
Viscosupplementation market is estimated to reach a value of ~US$ 4.8 Bn by the end of 2027
Viscosupplementation market is projected to expand at a CAGR of ~7% from 2019 to 2027
Viscosupplementation market is driven by rise in prevalence of osteoarthritis among the geriatric population
North America accounted for a major share of the global viscosupplementation market
Key players in the viscosupplementation market include Sanofi, Anika Therapeutics, Inc., Seikagaku Corporation, Zimmer Biomet, Ferring B.V.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Viscosupplementation Market
4. Market Overview
4.1. Introduction & Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porter’s Five Forces Analysis
4.4. Global Viscosupplementation Market Analysis and Forecast, 2017–2027
5. Market Outlook
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Key Industry Development
6. Global Viscosupplementation Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Global Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
6.2.1. Single Injection
6.2.2. Three Injections
6.2.3. Five Injections
6.3. Global Viscosupplementation Market Attractiveness, by Product Type
7. Global Viscosupplementation Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Global Viscosupplementation Market Value (US$) Forecast, by Application, 2017–2027
7.2.1. Knee Osteoarthritis
7.2.2. Hip Osteoarthritis
7.2.3. Hand Osteoarthritis
7.3. Global Viscosupplementation Market Attractiveness, by Application
8. Global Viscosupplementation Market Analysis and Forecast, by Source
8.1. Introduction & Definition
8.2. Global Viscosupplementation Market Value (US$) Forecast, by Source, 2017–2027
8.2.1. Animal
8.2.2. Non-animal
8.3. Global Viscosupplementation Market Attractiveness, by Source
9. Global Viscosupplementation Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Global Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
9.2.1. Hospital Pharmacies
9.2.2. Retail Pharmacies
9.2.3. Online Pharmacies
9.3. Global Viscosupplementation Market Attractiveness, by Distribution Channel
10. Global Viscosupplementation Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Viscosupplementation Market Value (US$ Mn) Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Viscosupplementation Market Attractiveness, by Region
11. North America Viscosupplementation Market Analysis and Forecast
11.1. Introduction
11.2. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
11.2.1. Single Injection
11.2.2. Three Injections
11.2.3. Five Injections
11.3. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027
11.3.1. Knee Osteoarthritis
11.3.2. Hip Osteoarthritis
11.3.3. Hand Osteoarthritis
11.4. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027
11.4.1. Animal
11.4.2. Non-animal
11.5. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. North America Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.6.1. U.S.
11.6.2. Canada
11.7. North America Viscosupplementation Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Application
11.7.3. By Source
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Viscosupplementation Market Analysis and Forecast
12.1. Introduction
12.2. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
12.2.1. Single Injection
12.2.2. Three Injections
12.2.3. Five Injections
12.3. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027
12.3.1. Knee Osteoarthritis
12.3.2. Hip Osteoarthritis
12.3.3. Hand Osteoarthritis
12.4. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027
12.4.1. Animal
12.4.2. Non-animal
12.5. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Viscosupplementation Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Application
12.7.3. By Source
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. Asia Pacific Viscosupplementation Market Analysis and Forecast
13.1. Introduction
13.2. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
13.2.1. Single Injection
13.2.2. Three Injections
13.2.3. Five Injections
13.3. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027
13.3.1. Knee Osteoarthritis
13.3.2. Hip Osteoarthritis
13.3.3. Hand Osteoarthritis
13.4. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027
13.4.1. Animal
13.4.2. Non-animal
13.5. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Pharmacies
13.6. Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Viscosupplementation Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Application
13.7.3. By Source
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region
14. Latin America Viscosupplementation Market Analysis and Forecast
14.1. Introduction
14.2. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
14.2.1. Single Injection
14.2.2. Three Injections
14.2.3. Five Injections
14.3. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027
14.3.1. Knee Osteoarthritis
14.3.2. Hip Osteoarthritis
14.3.3. Hand Osteoarthritis
14.4. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027
14.4.1. Animal
14.4.2. Non-animal
14.5. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Pharmacies
14.6. Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Viscosupplementation Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Application
14.7.3. By Source
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region
15. Middle East & Africa Viscosupplementation Market Analysis and Forecast
15.1. Introduction
15.2. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
15.2.1. Single Injection
15.2.2. Three Injections
15.2.3. Five Injections
15.3. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027
15.3.1. Knee Osteoarthritis
15.3.2. Hip Osteoarthritis
15.3.3. Hand Osteoarthritis
15.4. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027
15.4.1. Animal
15.4.2. Non-animal
15.5. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Online Pharmacies
15.6. Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Israel
15.6.4. Rest of Middle East & Africa
15.7. Middle East & Africa Viscosupplementation Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Application
15.7.3. By Source
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Competition Matrix
16.2. Market Share Analysis, by Company, 2018
16.3. Company Profiles
16.3.1. Sanofi
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. Anika Therapeutics, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Company Financials
16.3.2.3. Growth Strategies
16.3.2.4. SWOT Analysis
16.3.3. Zimmer Biomet Holdings, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Company Financials
16.3.3.3. Growth Strategies
16.3.3.4. SWOT Analysis
16.3.4. Ferring B.V.
16.3.4.1. Company Overview (HQ, Business Segments)
16.3.4.2. Growth Strategies
16.3.4.3. SWOT Analysis
16.3.5. Chugai Pharmaceutical Co., Limited
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Company Financials
16.3.5.3. Growth Strategies
16.3.5.4. SWOT Analysis
16.3.6. Bioventus, Inc.
16.3.6.1. Company Overview (HQ, Business Segments)
16.3.6.2. Growth Strategies
16.3.6.3. SWOT Analysis
16.3.7. Labrha International
16.3.7.1. Company Overview (HQ, Business Segments)
16.3.7.2. Growth Strategies
16.3.7.3. SWOT Analysis
16.3.8. Seikagaku Corporation
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Company Financials
16.3.8.3. Growth Strategies
16.3.8.4. SWOT Analysis
16.3.9. LG Chem
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Company Financials
16.3.9.3. Growth Strategies
16.3.9.4. SWOT Analysis
List of Tables
Table 01: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 02: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 03: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027
Table 04: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 05: Global Viscosupplementation Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 06: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 07: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 08: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027
Table 09: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 10: North America Viscosupplementation Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 11: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 12: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 13: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027
Table 14: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 15: Europe Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 17: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 18: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027
Table 19: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 20: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 22: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 23: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027
Table 24: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 25: Latin America Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 26: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 27: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 28: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Source, 2017–2027
Table 29: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 30: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
List of Figures
Figure 01: Global Viscosupplementation Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
Figure 02: Global Viscosupplementation Market Value (US$ Mn) Forecast, 2017–2027
Figure 03: Global Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 04: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Single Injection, 2017–2027
Figure 05: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Three Injections, 2017–2027
Figure 06: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Five Injections, 2017–2027
Figure 07: Global Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027
Figure 08: Global Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027
Figure 09: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Knee Osteoarthritis, 2017–2027
Figure 10: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hip Osteoarthritis, 2017–2027
Figure 11: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hand Osteoarthritis, 2017–2027
Figure 12: Global Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027
Figure 13: Global Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027
Figure 14: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Animal, 2017–2027
Figure 15: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Non-animal, 2017–2027
Figure 16: Global Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027
Figure 17: Global Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 18: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies, 2017–2027
Figure 19: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2017–2027
Figure 20: Global Viscosupplementation Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2017–2027
Figure 21: Global Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 22: Global Viscosupplementation Market Value Share Analysis, by Region, 2018 and 2027
Figure 23: Global Viscosupplementation Market Attractiveness Analysis, by Region, 2019–2027
Figure 24: North America Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 25: North America Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 26: North America Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027
Figure 27: North America Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027
Figure 28: North America Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027
Figure 29: North America Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027
Figure 30: North America Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027
Figure 31: North America Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 32: North America Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 33: North America Viscosupplementation Market Value Share Analysis, by Country, 2018 and 2027
Figure 34: North America Viscosupplementation Market Attractiveness Analysis, by Country, 2019–2027
Figure 35: Europe Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 36: Europe Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 37: Europe Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027
Figure 38: Europe Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027
Figure 39: Europe Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027
Figure 40: Europe Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027
Figure 41: Europe Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027
Figure 42: Europe Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 43: Europe Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 44: Europe Viscosupplementation Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 45: Europe Viscosupplementation Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 46: Asia Pacific Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 47: Asia Pacific Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 48: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027
Figure 49: Asia Pacific Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027
Figure 50: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027
Figure 51: Asia Pacific Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027
Figure 52: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027
Figure 53: Asia Pacific Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 54: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 55: Asia Pacific Viscosupplementation Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 56: Asia Pacific Viscosupplementation Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 57: Latin America Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 58: Latin America Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 59: Latin America Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027
Figure 60: Latin America Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027
Figure 61: Latin America Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027
Figure 62: Latin America Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027
Figure 63: Latin America Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027
Figure 64: Latin America Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 65: Latin America Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 66: Latin America Viscosupplementation Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 67: Latin America Viscosupplementation Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 68: Middle East & Africa Viscosupplementation Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 69: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 70: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Product Type, 2019–2027
Figure 71: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Application, 2018 and 2027
Figure 72: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Application, 2019–2027
Figure 73: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Source, 2018 and 2027
Figure 74: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Source, 2019–2027
Figure 75: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 76: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 77: Middle East & Africa Viscosupplementation Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 78: Middle East & Africa Viscosupplementation Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Viscosupplementation Market
